Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	221	620	641	1,191	1,323	1,369
Market Cap Growth	-65.29%	-3.27%	-46.17%	-9.94%	-3.39%	-16.27%
Enterprise Value	-20	-56	130	918	1,084	1,149
Last Close Price	11.17	20.36	15.83	39.76	48.02	58.51

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	7.13	-	-	-	-
PS Ratio	14.75	2.54	180.63	7888.64	-	68.11
PB Ratio	0.84	2.05	1.12	3.59	4.77	5.63
P/TBV Ratio	0.84	2.05	1.12	3.59	4.77	5.63
P/FCF Ratio	-	5.85	-	-	-	-
P/OCF Ratio	-	5.77	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	-	-	36.57	6076.87	-	57.16

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.06	0.06	0.03	0.04	0.05	0.00
Debt / EBITDA Ratio	-	0.21	-	-	-	-
Debt / FCF Ratio	-	0.16	-	-	-	-
Net Debt / Equity Ratio	-0.92	-0.89	-0.95	-0.95	-0.96	-0.94
Net Debt / EBITDA Ratio	2.50	-3.75	2.58	1.87	2.33	4.09
Net Debt / FCF Ratio	4.99	-2.55	3.32	2.49	3.73	3.62
Asset Turnover	0.03	0.51	0.01	0	-	0.08
Quick Ratio	21.47	15.10	20.56	13.63	16.92	20.96
Current Ratio	21.96	15.45	21.45	14.25	17.27	21.23
Return on Equity (ROE)	-17.16%	19.90%	-41.46%	-50.19%	-40.22%	-23.27%
Return on Assets (ROA)	-11.78%	9.25%	-26.73%	-31.39%	-25.53%	-13.43%
Return on Invested Capital (ROIC)	-481.72%	211.85%	-916.80%	-1251.82%	-887.57%	-1027.86%
Return on Capital Employed (ROCE)	-35.70%	22.20%	-35.80%	-49.20%	-39.60%	-23.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-37.55%	14.03%	-29.22%	-12.84%	-7.91%	-4.29%
FCF Yield	-21.89%	17.08%	-25.39%	-10.66%	-5.39%	-4.61%
Buyback Yield / Dilution	33.15%	-1.13%	-27.13%	-16.66%	-8.17%	-50.48%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error